Testing effectiveness (Phase 2)Study completedNCT00264433What this trial is testingThe Safety and Effects of ADH-1 Given Intravenously as a Single AgentWho this might be right forNeoplasms Adherex Technologies, Inc.
Early research (Phase 1)Study completedNCT00390676What this trial is testingADH 1 in Combination With Carboplatin, or Docetaxel or CapecitabineWho this might be right forNeoplasms Adherex Technologies, Inc.
Testing effectiveness (Phase 2)Looking for participantsNCT07529808What this trial is testingPhase 1/2 Study of BHB810 in Advanced Gastric and GEJ AdenocarcinomaWho this might be right forGastric CancerGastric AdenocarcinomaGastric (Stomach) Cancer+11 more BigHat Biosciences, Inc. 164
Very early researchLooking for participantsNCT06820424What this trial is testingSafety and Preliminary Efficacy of Anti-CDH17 CAR-T Cell Therapy in Patients with CDH17-positive Advanced Solid TumorsWho this might be right forCDH17-positive Advanced Solid Tumors 920th Hospital of Joint Logistics Support Force of People's Liberation Army of China 30
Very early researchLooking for participantsNCT06937567What this trial is testingCDH17 CAR-T Therapy in Advanced Malignant Solid TumorsWho this might be right forBiliary Tract CancerColorectal CarcinomaGastric Cancer, Metastatic+2 more Zhejiang University 36
Early research (Phase 1)UnknownNCT06501183What this trial is testingAnti-CDH17 CAR-T Cell Injection in Patients With CDH17-positive Advanced Malignant Solid TumorsWho this might be right forCDH17-positive Advanced Malignant Solid Tumors Shanghai Pudong Hospital 17
Testing effectiveness (Phase 2)Study completedNCT03620643What this trial is testingCrizotinib in Lobular Breast, Diffuse Gastric and Triple Negative Lobular Breast Cancer or CDH1-mutated Solid TumoursWho this might be right forLobular Breast CarcinomaGastric CancerTriple Negative Breast Cancer+1 more Royal Marsden NHS Foundation Trust 33